0
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description:
chemotherapy regimen consisting of etoposide, epirubicin, bleomycin, cyclophosphamide and prednisone; used in salvage treatment of stage IA-IIA Hodgkin's disease